These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7651437)

  • 1. Discrimination of DNA binding sites by mutant p53 proteins.
    Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
    Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
    Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
    PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of a consensus binding site for p53.
    el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
    Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of conserved domain II alters the sequence specificity of DNA binding by the p53 protein.
    Freeman J; Schmidt S; Scharer E; Iggo R
    EMBO J; 1994 Nov; 13(22):5393-400. PubMed ID: 7957105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mutant p53 temperature-sensitive DNA binding.
    Friedlander P; Legros Y; Soussi T; Prives C
    J Biol Chem; 1996 Oct; 271(41):25468-78. PubMed ID: 8810317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation.
    Cai BH; Chao CF; Huang HC; Lee HY; Kannagi R; Chen JY
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.
    Friedler A; Hansson LO; Veprintsev DB; Freund SM; Rippin TM; Nikolova PV; Proctor MR; Rüdiger S; Fersht AR
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):937-42. PubMed ID: 11782540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53.
    Cai BH; Chen JY; Lu MH; Chang LT; Lin HC; Chang YM; Chao CF
    Nucleic Acids Res; 2009 Apr; 37(6):1984-90. PubMed ID: 19208646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of DNA-binding loss upon single-point mutation in p53.
    Wright JD; Lim C
    J Biosci; 2007 Aug; 32(5):827-39. PubMed ID: 17914225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent mutations in the two repeats of yeast TATA-binding protein confer distinct TATA recognition specificities.
    Arndt KM; Wobbe CR; Ricupero-Hovasse S; Struhl K; Winston F
    Mol Cell Biol; 1994 Jun; 14(6):3719-28. PubMed ID: 8196615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 tagged sites from human genomic DNA.
    Tokino T; Thiagalingam S; el-Deiry WS; Waldman T; Kinzler KW; Vogelstein B
    Hum Mol Genet; 1994 Sep; 3(9):1537-42. PubMed ID: 7833908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based rescue of common tumor-derived p53 mutants.
    Wieczorek AM; Waterman JL; Waterman MJ; Halazonetis TD
    Nat Med; 1996 Oct; 2(10):1143-6. PubMed ID: 8837616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the p53 core domain L1 loop.
    Zupnick A; Prives C
    J Biol Chem; 2006 Jul; 281(29):20464-73. PubMed ID: 16687402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
    Ludes-Meyers JH; Subler MA; Shivakumar CV; Munoz RM; Jiang P; Bigger JE; Brown DR; Deb SP; Deb S
    Mol Cell Biol; 1996 Nov; 16(11):6009-19. PubMed ID: 8887630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 oligomerization and DNA looping are linked with transcriptional activation.
    Stenger JE; Tegtmeyer P; Mayr GA; Reed M; Wang Y; Wang P; Hough PV; Mastrangelo IA
    EMBO J; 1994 Dec; 13(24):6011-20. PubMed ID: 7813439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.